Hopes raised that drug could work well with immunotherapy for triple-negative breast cancer patients
Aspirin is being trialled as part of a potential treatment for an aggressive form of breast cancer.
Researchers hope the cheap and widely available drug could work well when combined with immunotherapy for patients with triple-negative breast cancer.
